<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Different factors interact to develop <z:hpo ids='HP_0002180'>neurodegeneration</z:hpo> in patients with <z:hpo ids='HP_0000726'>dementia</z:hpo> and other <z:e sem="disease" ids="C0524851" disease_type="Disease or Syndrome" abbrv="">neurodegenerative disorders</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain><z:mp ids='MP_0003674'>Oxidative stress</z:mp> and epsilon 4 allele of the <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> E are associated with significant alteration in <z:chebi fb="23" ids="18059">lipid</z:chebi> metabolism, in turn connected to a variety of <z:hpo ids='HP_0002180'>neurodegenerative diseases</z:hpo> and aging </plain></SENT>
<SENT sid="2" pm="."><plain>Thus, a better understanding of the pathogenetic pathways associated to <z:chebi fb="23" ids="18059">lipid</z:chebi> dyshomeostasis may elucidate the causes of neurodegenerative processes </plain></SENT>
<SENT sid="3" pm="."><plain>To address this issue, we evaluated the effects of <z:chebi fb="11" ids="22586">antioxidant</z:chebi> status and APOE genotype on <z:hpo ids='HP_0002180'>neurodegeneration</z:hpo> in patients with <z:hpo ids='HP_0000726'>dementia</z:hpo> of Alzheimer's type (AD), with vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VaD), and in elderly healthy controls </plain></SENT>
<SENT sid="4" pm="."><plain>Eighty-two AD, 42 VaD patients and 26 healthy controls were recruited and underwent medial temporal lobe <z:mpath ids='MPATH_127'>atrophy</z:mpath> (MTA) assessment, white matter hyperintensities' rating (WMH), serum total <z:chebi fb="11" ids="22586">antioxidant</z:chebi> status assaying (TAS) and APOE genotyping </plain></SENT>
<SENT sid="5" pm="."><plain>A logistic regression algorithm applied to our data revealed that a 0.01 mmol/L decrease of TAS concentration increased the probability of MTA by 24% (p = 0.038) and that carriers of the APOE-ε4 allele showed higher WMH scores (p=0.018), confirming that small variations in <z:chebi fb="11" ids="22586">antioxidant</z:chebi> systems homeostasis are associated with relevant modifications of disease risk </plain></SENT>
<SENT sid="6" pm="."><plain>Furthermore, in individuals with analogous TAS values, the presence of ε4 allele increased the predicted probability of having MTA </plain></SENT>
<SENT sid="7" pm="."><plain>These outcomes further sustain the interaction of <z:mp ids='MP_0003674'>oxidative stress</z:mp> and APOE genotype to <z:hpo ids='HP_0002180'>neurodegeneration</z:hpo> </plain></SENT>
</text></document>